Business ProfileforXlear, Inc.

The following describes a pending government action that has been formally brought by a government agency but has not yet been resolved. We are providing a summary of the governments allegations, which have not yet been proven.

On October 28, 2021, the Federal Trade Commission sued Xlear, Inc., for violating the COVID-19 Consumer Protection Act, alleging that it falsely pitched its saline nasal sprays as an effective way to prevent and treat COVID-19. In its lawsuit against Xlear, Inc. and its owner, the FTC is asking a federal court to impose monetary penalties on the business and bar them from continuing to make such false and unsupported claims. 

Xlear, Inc. sells products including nasal sprays, dental care products, and sweeteners. The company's nasal sprays marketed under the Xlear Sinus Care brand contain, among other things, xylitol and grapefruit seed extract. Xlear sells these sprays on Amazon.com and through retailers like Rite-Aid, CVS, Walgreens and Target. 

According to the complaint filed by FTC, since at least March 2020, Xlear and its founder and president, Nathan Jones, have promoted Xlear nasal sprays by falsely claiming they provide four hours of protection against infection from the coronavirus and therefore are "a simple, safe, and cheap option that could be an effective solution to the pandemic." In reality, the company has conducted no clinical trials to support its COVID-related claims and its advertising grossly misrepresented the purported findings and relevance of several scientific studies, according to the FTC. A warning letter was sent to the business in July 2020, the business promised to remove the claims from their website and other platrorms, but then continued making them, according to the complaint.